Patents Examined by Lauren P Farrar
  • Patent number: 10994114
    Abstract: A fluid pathway connection includes a piercing member, a connection hub, and a sliding pierceable seal, wherein the sliding pierceable seal is configured to move from a first position, where the piercing member is initially retained within a sterile cavity between the connection hub and the sliding pierceable seal, to a second position, where the pierceable seal has been penetrated by the piercing member. A filter may be utilized to enclose the sterile cavity from the outside environment. The fluid pathway connection may further be configured to move to a third position where one or more interconnects and/or one or more corresponding contacts are permitted to transmit a signal to the user. Such fluid pathway connections may be integrated into a drug container having a barrel and a plunger seal. A drug delivery pump includes such integrated fluid pathway connections and drug containers.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: May 4, 2021
    Assignee: UNL Holdings LLC
    Inventors: Matthew J. Clemente, Ian B. Hanson, Paul F. Bente, IV, Ryan M. Agard, Nicholas J. Ciccarelli
  • Patent number: 10994070
    Abstract: A device and method for testing and inspecting the integrity of an autoinjector device is disclosed. The autoinjector devices includes a medication container, a housing that receives the medication container, the housing including a plurality of electrodes arranged circumferentially relative to the medication container, and a plurality of electrical contacts corresponding to the plurality of electrodes and in electrical communication therewith, the electrical contacts being accessible from the exterior of the autoinjector device, wherein a circuit between at least one pair of electrodes, measured at the electrical contacts, indicates a defect in the medication container. A method of testing the integrity of the autoinjector device is also disclose, wherein a voltage is applied to the electrical contacts in order to determine the integrity of the medication container in the autoinjector device. Accordingly, defects in the pre-packaged medication container in the autoinjector device may be detected.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: May 4, 2021
    Assignee: Packaging Technologies & Inspection, LLC
    Inventors: Oliver Stauffer, Anton Stauffer
  • Patent number: 10993725
    Abstract: Methods and apparatuses for embolizing an artery in a living subject using a catheter are disclosed. The catheter has a lumen and also has a balloon located near the distal end of the catheter. The distal end of the catheter is introduced into the artery, and the balloon is inflated to form a seal that prevents blood in the artery from flowing past the balloon. A mixture that includes embolic particles and contrast agent is injected through the lumen into the portion of the artery that is distally beyond the balloon. The subject's own blood or another fluid that contains platelets is injected through the lumen into the portion of the artery that is distally beyond the balloon. Subsequently, the balloon is deflated and the distal end of the catheter is withdrawn.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: May 4, 2021
    Assignee: Endobar Sortions LLC
    Inventors: Nickolas Kipshidze, Ronald J. Solar
  • Patent number: 10987453
    Abstract: A medical device is provided comprising a first port; a second port in fluid communication with the first port; and a third port in selective fluid communication with both the first port and the second port; a sealing membrane disposed between the third port and both the first port and the second port, the sealing membrane is configured to move between a first position preventing fluid communication between the third port and both the first port and the second port and a second position allowing fluid communication between the third port and the first port, wherein movement of a fluid supplied to the medical device at the third port moves the sealing membrane from the first position to the second position.
    Type: Grant
    Filed: September 7, 2017
    Date of Patent: April 27, 2021
    Assignee: Gyros Acmi, Inc.
    Inventor: Ming J. Cheng
  • Patent number: 10987466
    Abstract: A fluid delivery device comprises a housing having a base including a bottom surface; a locking assembly including a cartridge receiver configured to receive a cartridge, the cartridge having a fluid reservoir and a septum configured to be generally perpendicular to the bottom surface when the cartridge is engaged with the cartridge receiver; and a needle assembly having a needle, the needle having a delivery end, a fluid coupling end, and a central portion located between the delivery end and the fluid coupling end, the needle assembly configured to move in laterally relative to the base to a first position and vertically relative to the base to a second position. The locking assembly prevents the needle assembly from moving to one or both of the first and second positions unless the cartridge is engaged with the cartridge receiver.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: April 27, 2021
    Assignee: ZEALAND PHARMA A/S
    Inventors: Matthew P. Johnson, Christopher C. Gregory
  • Patent number: 10987502
    Abstract: The microneedle sheet according to an embodiment comprises a plurality of microneedles formed on a sheet generally along a main surface of the sheet; a bending resistance of the sheet as measured in accordance with a 45° cantilever method defined by JIS L 1096:2010 is 4.2 cm to 12.5 cm; and a material of the sheet is a biodegradable polymer. The microneedles rise from the main surface when the sheet is bent, and the raised microneedles pierce the skin.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: April 27, 2021
    Assignee: HISAMITSU PHARMACEUTICAL CO., INC.
    Inventors: Ryusuke Fudoji, Naoki Yamamoto
  • Patent number: 10987128
    Abstract: A surgical cannula assembly includes an elongate cannula member having a plurality of longitudinal ribs extending along the longitudinal axis with adjacent longitudinal ribs defining a longitudinal channel therebetween, a fluid port mounted adjacent the proximal end of the cannula member and configured for coupling to a source of inflation fluids, a conduit positioned within at least one longitudinal channel of the cannula member and in fluid communication with the fluid port, and an expandable balloon mounted adjacent the distal end of the cannula member and in fluid communication with the conduit. The expandable balloon is configured to transition from an initial unexpanded condition to an at least partially expanded condition upon passage and entry of inflation fluids from the fluid port, through the conduit and within an internal volume of the expandable balloon.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: April 27, 2021
    Assignee: COVIDIEN LP
    Inventors: Oksana Buyda, Christopher Tokarz, Amanda Adinolfi
  • Patent number: 10987500
    Abstract: A nanochannel delivery device and method of manufacturing and use. The nanochannel delivery device comprises an inlet, an outlet, electrodes and a nanochannel. The nanochannel may be oriented parallel to the primary plane of the nanochannel delivery device. The inlet and outlet may be in direct fluid communication with the nanochannel.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: April 27, 2021
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Daniel Fine, Alessandro Grattoni, Mauro Ferrari, Xuewu Liu, Randal Goodall, Sharath Hosali
  • Patent number: 10980972
    Abstract: A catheter having a catheter shaft and a tip. The catheter shaft includes an inner layer, a first reinforcing layer disposed around an outer periphery of the inner layer, an intermediate layer, a second reinforcing layer disposed around an outer periphery of the intermediate layer, and an outer layer that covers the second reinforcing layer. The tip includes a proximal end portion that extends in an axial direction of the catheter and is joined to at least the intermediate layer and the outer layer, between the first reinforcing layer and the second reinforcing layer. The proximal end portion increases the joining strength between the intermediate layer and the tip and the joining strength between the outer layer and the tip. As a result, it is possible to prevent the tip from easily detaching from the catheter shaft.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: April 20, 2021
    Assignee: ASAHI INTECC CO., LTD.
    Inventor: Hirotomo Shimizu
  • Patent number: 10973396
    Abstract: A system and method for enhancing diagnosis and treatment including an extended working channel defining an elongated passageway and adapted to extend through the bronchoscope and into a luminal network, an opening operably associated with the extended working channel and in fluid communication with the luminal network, and a medical instrument configured for insertion through the extended working channel, wherein during operation, apposition of tissue on the extended working channel or medical instrument isolates at least a portion of a luminal network in which the extended working channel is inserted.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: April 13, 2021
    Assignee: COVIDIEN LP
    Inventor: William S. Krimsky
  • Patent number: 10973987
    Abstract: The present disclosure relates to a drug delivery device, including: a body adapted to retain a medicament cartridge, a cap attachable to a distal end of the body to cover an opening thereof, an activation mechanism arranged within the body, wherein the cap includes an activation feature adapted to be inserted into an activation opening of the body in order to actuate the activation mechanism or allow actuation thereof.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: April 13, 2021
    Assignee: Sanofi-Aventis Deutschland GMBH
    Inventors: Stefan Wendland, Michael Harms
  • Patent number: 10973984
    Abstract: An injection device including a needle protection system, said injection device including a delivery needle (10) that is provided with a delivery orifice (11), said protection system comprising a removable needle guard (20) that, in a non-dispensing position, is adapted to be arranged on said needle (10) so as to protect and isolate said delivery orifice (11) of said needle (10), said needle guard (20) including an isolator portion (21) made of flexible material, said delivery orifice (11) of the needle (10) being poked into said isolator portion (21) in the non-dispensing position, said needle guard (10) including at least one outwardly-radial projection (25), said protection system further comprising an outer cap (30) that is provided with grip means (35, 35?, 36; 38; 300) that are adapted to co-operate with said at least one radial projection (25) of said needle guard (20), such that moving said outer cap (30) in the longitudinal direction of said needle (10), away from said delivery orifice (11), removes
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: April 13, 2021
    Assignee: APTAR STELMI SAS
    Inventors: Arnaud Fournier, Ghislain Fournier, Mickael Swal
  • Patent number: 10967127
    Abstract: This pharmaceutical injection device may be provided with a main body case, a pharmaceutical syringe mounting portion, a piston, a piston feed screw or the like, and a cover. At a first end, the main body case may have an injection needle mounting portion to which an injection needle is mounted. The pharmaceutical syringe mounting portion may be provided inside the main body case, and a pharmaceutical syringe may be mounted thereto. The piston may be provided movably with respect to the pharmaceutical syringe that is mounted to the pharmaceutical syringe mounting portion. The piston feed screw or the like drives the piston. The cover may be provided on the first end side of the main body case and operates to open and close the injection needle mounting portion.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: April 6, 2021
    Assignee: PHC HOLDINGS CORPORATION
    Inventors: Kenji Murakami, Mitsuteru Fujimoto
  • Patent number: 10967107
    Abstract: Described herein are devices and methods for irrigating and suctioning fluids from the lumens or cavities of a mammalian body. The devices include a malleable irrigation tube and a suction tube that is slidably mounted upon the irrigation tube.
    Type: Grant
    Filed: April 28, 2016
    Date of Patent: April 6, 2021
    Assignee: Entellus Medical, Inc.
    Inventors: Andrew T. Forsberg, John R. Drontle, Anthony J. Hanson
  • Patent number: 10967168
    Abstract: A medical fluid control device with a fluid flow housing has at least one attachment port for attaching and removing an external medical fluid-guiding component and at least one connection port for connecting to a further functional component of the medical fluid conduction system, and with an adjustment member for controlling a flow of fluid relative to the at least one attachment port and/or the at least one connection port. A particulate filter with a pore width of between 2 ?m and 15 ?m is integrated in the attachment port.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: April 6, 2021
    Assignee: B. BRAUN MELSUNGEN AG
    Inventor: Ralf Kunschak
  • Patent number: 10959941
    Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: March 30, 2021
    Assignee: Glaukos Corporation
    Inventor: David S. Haffner
  • Patent number: 10952758
    Abstract: A method of removing a kidney stone from the kidney and ureter of a human includes the steps of introducing a laminar flowing fluid via a ureteroscope into the ureter or kidney and proximal the kidney stone and flowing inward toward the kidney and then switching the laminar flow to a turbulent flow which causes a reverse flow that moves the kidney stone in a direction away from the kidney and down the ureter toward the bladder where the stone may be removed using a wire basket. In one step the kidney stone may first be fragmented into smaller kidney stones or fragments prior to switching to the turbulent flow.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: March 23, 2021
    Inventor: Jason M. Evans
  • Patent number: 10953220
    Abstract: A device with in situ anode and cathode microneedles is used, either with or without any cosmetic, cosmeceutical, nutraceutical, and/or pharmaceutical composition or formulation. The in situ anode and cathode microneedles form battery cells or half-cells when placed in contact with an electrolyte found in bodily interface tissue, to produce an electromotive force without any additional chemical battery or power source. The microneedles may be composed of, or may carry (e.g., be coated with) electrical potential material(s) that has or have an electrical potential relative to an electrolyte in the bodily interface material. A first number of microneedles may, for instance, include a first electrical potential material having a first electrical potential. A second number of microneedles may, for instance, include a second electrical potential material having a second electrical potential.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: March 23, 2021
    Assignee: CATURA CORPORATION
    Inventors: Glenn Godden, Darrick Carter
  • Patent number: 10953163
    Abstract: In a medicament dispensing device (1), when a medicament preparation-containing syringe (11) is replaced, a microprocessor (23) detects the time at which the replacement is performed as the time of the start of use of the preparation, and counts the elapsed time after the use of the preparation has started. Then, the microprocessor (23) notifies the result of the counting by a LCD (10), etc. to the user. Also, the microprocessor (23) detects that a syringe needle for dispensing the preparation has been mounted, and after detecting the mounting of the syringe needle, the microprocessor (23) counts the elapsed time after the start of use of the preparation. When an effective use period has expired, the microprocessor (23) issues a message in a step S17 that the effective period of a medicament has expired.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: March 23, 2021
    Assignee: PHC HOLDINGS CORPORATION
    Inventors: Atsushi Watanabe, Seiji Kikuchi, Tsuguhiro Kondo
  • Patent number: 10952666
    Abstract: Treatment controllers and methods are provided that can be integrated with treatment systems, such as peritoneal dialysis systems, hemodialysis systems, and nocturnal treatment systems, to manage execution of treatment operations or a course of treatment based on timing information and/or patient sleep state.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: March 23, 2021
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Daniel Schmidt, Bert D. Egley